-
venBio is a life sciences investment firm that partners with industry leaders to build game-changing medicines and technologies, with a focus on novel therapeutics for unmet medical needs.
Latest News
-
2021
28JANArtiva Biotherapeutics Announces Exclusive Worldwide Collaboration and License Agreement with Merck to Develop Candidate CAR-NK Cell Therapies
posted by admin in Latest NewsArtiva Biotherapeutics Announces Exclusive Worldwide Collaboration and License Agreement with Merck to Develop Candidate CAR-NK Cell Therapies...
Read More -
2021
08JANPositive Phase 2b ICONA Interim Results for icosabutate in NASH Patients
posted by admin in Latest NewsPositive Phase 2b ICONA Interim Results for icosabutate in NASH Patients...
Read More -
2021
05JANArtiva Biotherapeutics Announces Appointment of Dr. Fred Aslan as President and CEO
posted by admin in Latest NewsArtiva Biotherapeutics Announces Appointment of Dr. Fred Aslan as President and CEO...
Read More -
2020
08DECBarely two months after unveiling a new breed of radiopharmaceuticals, RayzeBio brings total haul to $150M
posted by admin in Latest NewsBarely two months after unveiling a new breed of radiopharmaceuticals, RayzeBio brings total haul to $150M...
Read More